ProteoTech's Grant

ProteoTech raised a round of funding on April 16, 1999. Investors include National Institutes of Health.

ProteoTech is a private drug development company focused on targeting amyloid diseases. ProteoTech is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of…

Articles about ProteoTech's Grant: